Table 1.

Study Population^*

	N (%)
HCV-infected	597
Median age (interquartile range [IQR])	50 (45-54)
Male gender	423 (71)
African-American race	570 (95)
HCV/HIV co-infected	188 (31)
HCV genotype 1†	415 (97)
HCV RNA positive‡	470 (83)
Median duration of HCV infection (years)	29 (22-35)
Any drug use	253 (42)
Injection drug use
None	421 (71)
<daily	80 (13)
≥daily	93 (16)
Methadone maintenance	138 (23)
Alcohol use	242 (41)
Depression§
<16	124 (69)
16-23	21 (12)
≥ 23	34 (19)
Homeless	66 (11)
Incarcerated	59 (10)
Health insurance
None	219 (37)
Medicaid	211 (36)
Other	164 (28)

^*Except where otherwise indicated, characteristics refer to the six month-period prior to the survey. Data are presented as n(%) except where otherwise indicated

^†Genotype results not available for 169 persons; Includes 1 individual with genotype 1a/2

^‡HCV RNA testing was performed in 1994-1995; Available for 567 persons

^§Depression scores based on Centers for Epidemiologic Studies Depression (CES-D) scale; Only available for 179 persons